Overview
Neurological channelopathy of the central nervous system due to a genetic chloride channel defect is a rare inherited brain disorder caused by mutations in genes that control chloride channels — tiny protein pores that help nerve cells communicate properly. Chloride channels play a key role in regulating how electrically active nerve cells are. When these channels do not work correctly, nerve cells in the brain can become overexcited or fail to send signals in the right way, leading to a range of neurological problems. The most well-known condition in this group is caused by mutations in the CLCN2 gene, and the group also includes disorders linked to other chloride channel genes affecting the central nervous system. Symptoms can include seizures, muscle stiffness or weakness, problems with balance and coordination, and in some cases changes in thinking or learning. The exact symptoms depend on which gene is affected and how severely the channel is disrupted. Treatment is mainly focused on managing symptoms, especially seizures, using anti-seizure medications. There is currently no cure. Some people respond well to medication and lead relatively normal lives, while others may have more persistent challenges. Ongoing research into how chloride channels work is opening new doors for more targeted therapies in the future.
Key symptoms:
Seizures or epileptic episodesMuscle stiffness or spasmsMuscle weaknessProblems with balance and coordinationDifficulty walking steadilyInvoluntary eye movements (nystagmus)Learning difficulties or intellectual disabilityDelayed development in childrenFatigue and low energySpeech difficultiesSensitivity to light or sound during episodes
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Neurological channelopathy of the central nervous system due to a genetic chloride channel defect.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Neurological channelopathy of the central nervous system due to a genetic chloride channel defect at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Neurological channelopathy of the central nervous system due to a genetic chloride channel defect.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Neurological channelopathy of the central nervous system due to a genetic chloride channel defect.
Community
No community posts yet. Be the first to share your experience with Neurological channelopathy of the central nervous system due to a genetic chloride channel defect.
Start the conversation →Latest news about Neurological channelopathy of the central nervous system due to a genetic chloride channel defect
No recent news articles for Neurological channelopathy of the central nervous system due to a genetic chloride channel defect.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific gene mutation has been found, and what does that mean for my symptoms and outlook?,What type of seizures do I have, and which anti-seizure medication is best suited for my specific condition?,Are there any medications or triggers I should avoid that could make my symptoms worse?,Should other family members be tested for the same genetic mutation?,Are there any clinical trials or research studies I might be eligible for?,What therapies — such as physical, occupational, or speech therapy — would benefit me most?,What should I do in a seizure emergency, and when should I call for an ambulance?
Common questions about Neurological channelopathy of the central nervous system due to a genetic chloride channel defect
What is Neurological channelopathy of the central nervous system due to a genetic chloride channel defect?
Neurological channelopathy of the central nervous system due to a genetic chloride channel defect is a rare inherited brain disorder caused by mutations in genes that control chloride channels — tiny protein pores that help nerve cells communicate properly. Chloride channels play a key role in regulating how electrically active nerve cells are. When these channels do not work correctly, nerve cells in the brain can become overexcited or fail to send signals in the right way, leading to a range of neurological problems. The most well-known condition in this group is caused by mutations in the